Transcatheter closure of atrial septal defect with Amplatzer® device in children aged less than 10 years old: Immediate and late follow‐up

Rossi, R; Cardoso, Cristiano de Oliveira; Machado, Paulo Renato; Francois, Lisia Galant; Horowitz, Estela Suzana Kleiman; Sarmento‐Leite, Rogério

doi:10.1002/ccd.21361

Cited by 27 publications

(25 citation statements)

References 106 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The procedure is safe, effective and reproducible in different hands, even for patients with more complex anatomies such as multifenestrated and/or aneurysmal septum, large defects and those associated with deficient rims 141516171819202122. Because children with secundum ASDs are usually asymptomatic, with normal weight gain and limited respiratory repercussion (repeat infections or wheezing, or both), the procedure is preferentially performed when the patient weighs over 20 kg.…”

Section: Outcomes After Medical Surgical or Interventional Treatmentmentioning

confidence: 99%

“…Because children with secundum ASDs are usually asymptomatic, with normal weight gain and limited respiratory repercussion (repeat infections or wheezing, or both), the procedure is preferentially performed when the patient weighs over 20 kg. Several devices have been used including the Buttoned device, Amplatzer Septal Occluder (AGA Medical, Plymouth, Minnesota, USA), Helex (WL Gore and Associates, Flagstaff, Arizona, USA) and Intrasept (Cardia, Eagan, Minnesota, USA) 141516171819202122. The experience with the CardioSEAL/Starflex/Biostar (NMT Medical, Boston, Massachusetts, USA) device has been limited in South America.…”

Section: Outcomes After Medical Surgical or Interventional Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Paediatric and congenital heart disease in South America: an overview

Pedra

Haddad²,

Pedra³

et al. 2009

Heart

View full text Add to dashboard Cite

Congenital heart diseases are one of the most common structural defects present at birth, with an approximate incidence of 8 per 1000 live births. As most countries in South America have a high birth rate, they are a significant public health concern. This paper provides a brief overview of the burden of congenital heart disease in South America, focusing on its local prevalence, facilities for treatment and outcomes after medical, surgical or catheter intervention for the most common diseases.

show abstract

Section: Outcomes After Medical Surgical or Interventional Treatmentmentioning

confidence: 99%

Section: Outcomes After Medical Surgical or Interventional Treatmentmentioning

confidence: 99%

Paediatric and congenital heart disease in South America: an overview

Pedra

Haddad²,

Pedra³

et al. 2009

Heart

View full text Add to dashboard Cite

show abstract

“…Also in recent years, using alternative approaches, it was implemented the percutaneous or transapical of aortic valve implants and endovascular devices, such as aortic endoprosthesis and rings for annular reduction for mitral valve and devices for occlusion of congenital atrioventricular defects [4][5][6]8].…”

Section: Discussionmentioning

confidence: 99%

“…In these examples, are included the aortic stents, devices for occlusion of congenital clefts (Amplatzers) and transcatheter aortic valve implants [4][5][6][7][8].…”

Section: Introductionmentioning

confidence: 99%

Cirurgia cardíaca videoassistida

Júnior¹,

Pereira²,

Martins³

et al. 2012

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

“…These findings have been confirmed even with the usage of various kinds of devices and in different patients’ age group. [4567] Some studies have even demonstrated a significant functional improvement of ASD in patients with mild (RV) dilatation and lower systolic pulmonary arterial pressure (SPAP). [8]…”

Section: Introductionmentioning

confidence: 99%

Long-term results after percutaneous closure of atrial septal defect: Cardiac remodeling and quality of life

Mangiafico

Monte

Tropea

et al. 2013

J Cardiovasc Echography

View full text Add to dashboard Cite

Background:Atrial septal defect (ASD) represents a common congenital heart malformation, cause of right ventricle (RV) volume overload, pulmonary hypertension, atrial arrhythmias, and paradoxical emboli. Percutaneous closure represents the treatment of choice for ASD. However, it is still difficult to associate symptoms to the success of ASD treatment.Objective:To investigate any possible correlation between transthoracic echocardiography (TTE) findings and patients’ symptoms after ASD treatment.Materials and Methods:Thirty patients (mean age 49 ± 17 years; 10 younger ≤40 years and 20 > 40 years) underwent percutaneous closure of ASD type ostium secundum. Every patient underwent clinical examination, electrocardiogram (ECG) and TTE before procedure and at 1, 6, and 12 months after procedure and a multichoice questionnaire to collect patients’ symptoms and complain severity.Statistical analysis:Continuous variables were summarized by means and standard deviation. Estimates of occurrence of events were expressed as percentages. Comparison between mean follow-ups was achieved using paired t-test sample.Results:At end of follow-up, TTE showed a decrease of RV dimensions (34.4 vs 37.5 mm preclosure; P = 0.01), pulmonary artery systolic pressure (PAPs 28.4 vs 39.5 mmHg; P = 0.00003), atrial dimensions (51 vs 56 mm; P = 0.085), and of right myocardial performance index (MPI; 0.39 vs 0.42; P = 0.05). PAPs was significantly reduced in group more than 40-years-old (P = 0.00004), while the reduction was not significant in the less or equal than 40 years of age (P = 0.08) group because the baseline value was significantly lower. Many patients after procedure complained headache, insomnia, palpitations, fatigue, and dyspnea; but no cardiac morphological abnormalities related to symptoms were found.Conclusions:Our data showed a great improvement in symptoms and positive cardiac remodeling after closure of ASD, more effective in elderly patients compared to younger patients. The symptoms are not correlated with the principal disease or procedure.

show abstract

Transcatheter closure of atrial septal defect with Amplatzer® device in children aged less than 10 years old: Immediate and late follow‐up

Abstract: Secundum atrial septal defect closure can be safely and successfully performed with the Amplatzer septal occluder in children younger than 10 years old.

Cited by 27 publications

References 106 publications

Paediatric and congenital heart disease in South America: an overview

Paediatric and congenital heart disease in South America: an overview

Cirurgia cardíaca videoassistida

Long-term results after percutaneous closure of atrial septal defect: Cardiac remodeling and quality of life

Contact Info

Product

Resources

About